MusclePharm Corporation

MusclePharm (OTCMKTS:MSLP) & Hepion Pharmaceuticals (NASDAQ:HEPA) Critical Contrast

MusclePharm (OTCMKTS:MSLP) and Merck KGaA (OTCMKTS:MKGAF) Head-To-Head Analysis

MusclePharm Files For Uplisting IPO To Nasdaq

MusclePharm to Present at the LD Micro Invitational XII Conference

MusclePharm Corporation (MSLP) CEO Ryan Drexler on Q1 2022 Results - Earnings Call Transcript

MusclePharm to Announce Fourth Quarter and Full Year 2021 Financial Results on Thursday, April 14, 2022

MusclePharm Corporation (MSLP) CEO Ryan Drexler on Q3 2021 Results - Earnings Call Transcript

MusclePharm to Announce Third Quarter 2021 Financial Results on Monday, November 15, 2021

MusclePharm Announces Closing of $7.0 Million Senior Secured Notes Offering

MusclePharm Closes More Pre-Orders Reaching Pre-Production Sales Goal of $1 Million for MP Performance Energy Line Through Collective Distributors

MusclePharm's (MSLP) CEO Ryan Drexler on Q2 2021 Results - Earnings Call Transcript

MusclePharm Increases Sequential Sales in Second Quarter 2021 Despite Continued Industry Wide Supply Chain Challenges

MusclePharm Announces Colorado Distribution Partnership with New Age, Inc.

MusclePharm Closes Potential $7.3 Million Liability with IRS

MusclePharm Names 11th Largest Accounting Firm, Moss Adams, as Independent Auditor

MusclePharm Closes More Pre-Orders Bringing Pre-Production Sales Orders to Approximately $600,000

MusclePharm Closes $500,000 in Initial Orders for MP Performance Energy Line Through Collective Distributors

MusclePharm Appoints New Independent Board Member

MusclePharm Corporation's (MSLP) CEO Ryan Drexler on Q1 2021 Results - Earnings Call Transcript

MusclePharm Delivers Profitable First Quarter 2021 Despite Industry Wide Supply Shortages